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Abstract. The Lubombo Spatial Development Initiative is a joint development program between the governments
of Mozambique, Swaziland, and South Africa, which includes malaria control as a core component of the initiative.
Vector control through indoor residual spraying (IRS) was incrementally introduced in southern Mozambique between
November 2000 and February 2004. Surveillance to monitor its impact was conducted by annual cross-sectional surveys
to assess the prevalence of Plasmodium falciparum infection, entomologic monitoring, and malaria case notification in
neighboring South Africa and Swaziland. In southern Mozambique, there was a significant reduction in P. falciparum
prevalence after the implementation of IRS, with an overall relative risk of 0.74 for each intervention year (P < 0.001),
ranging from 0.66 after the first year to 0.93 after the fifth intervention year. Substantial reductions in notified malaria
cases were reported in South Africa and Swaziland over the same period. The success of the program in reducing malaria
transmission throughout the target area provides a strong argument for investment in regional malaria control.
INTRODUCTION
The Lubombo Spatial Development Initiative (LSDI) is a
joint program between the governments of Mozambique,
Swaziland, and South Africa to develop the Lubombo region
of eastern Swaziland, southern Mozambique (Maputo prov-
ince), and northeastern KwaZulu-Natal into a globally com-
petitive economic zone (Figure 1). The communities in this
high malaria risk area include some of the poorest in the
region, with high unemployment levels.1 There is evidence
that malaria control is a necessary precursor to development
in malaria-endemic areas.2 This contention is supported by
well-documented negative impacts of malaria on tourism and
agricultural development in the 1930s, before control mea-
sures were implemented.3 Thus, a malaria control program
was initiated as a core component of the LSDI.
In July 1999, the heads of state of the three countries signed
a protocol of understanding creating a platform for regional
cooperation and delivery. In October 1999, a tri-national ma-
laria program was launched at a ministerial level between the
three countries.
The highest-risk malaria areas in South Africa and Swazi-
land border southern Mozambique, and there is ongoing mi-
gration between these neighboring areas.3 The malaria con-
trol program of the LSDI aimed to optimize the effectiveness
of malaria control in the highest-risk malaria regions of South
Africa and Swaziland bordering Mozambique, but placed pri-
mary emphasis on extending malaria control into southern
Mozambique.
We report on malaria control activities from December
1999 to June 2005 in the LSDI areas of Mozambique, South
Africa, and Swaziland and assess the impact of the control
program on malaria prevalence, malaria incidence, and ento-
mology in this region.
MATERIALS AND METHODS
Interventions. Anopheles vector control through indoor re-
sidual spraying (IRS) with insecticide and parasite control
through first-line treatment with artemisinin-based combina-
tion therapy (ACT) were the two key malaria control inter-
ventions implemented.
In Mozambique, twice annual IRS with bendiocarb insec-
ticide (Bayer CropScience, Mannheim, Germany) at 400 mg/
m2 was introduced incrementally in five zones (1, 1A, 2, 2A,
3) in Maputo Province. Starting in Zone 1 (Figure 1) in No-
vember 2000, the program was extended to Zones 1A and 2A
in February 2001, Zone 2 in October 2002, and Zone 3 in
February 2004 (Table 1). In Zone 2A, IRS was interrupted
from 2001 to 2002 because of resource constraints, but re-
sumed in the second half of 2003 under a grant from the
Global Fund against AIDS, Tuberculosis and Malaria. The
five zones comprise an area of ∼21,000 km2, with a population
of ∼800,000, covering seven districts.
In Swaziland, IRS with dichloro-diphenyl-dicloroethylene
(DDT; 2 g/m2) had started in 1981.4 Spraying dates during the
study period were September to December each year from
1999 to 2005. In South Africa, IRS with DDT started in 1946.5
In 1996, the policy changed to pyrethroid use. However, DDT
was reintroduced in KwaZulu-Natal Province5 in 2000 after
the detection of monooxygenase-based pyrethroid insecticide
resistance, which led to program failure but which does not
confer cross-resistance to DDT.6,7 Since 2001, DDT IRS was
conducted in October each year in both Mpumalanga and
KwaZulu-Natal provinces. Pyrethroid insecticide continued
to be used in homes with painted walls because of the visible
residues of DDT on such surfaces. In KwaZulu-Natal, ben-
diocarb (400 mg/m2) was sprayed twice annually in homes
with painted walls during the 2004/2005 malaria season.
All spraying was conducted using Hudson Xpert pumps
(Hudson Manufacturing Co., Chicago, IL) with appropriate
nozzles. Spraying personnel were trained in spraying tech-
niques, safety measures, and personal protection equipment
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appropriate to the insecticide used. Given environmental con-
cerns related to DDT use, the South African Endangered
Wildlife Trust assisted in preparing training material and au-
dited use, safety, and disposal of DDT.
Before the introduction of artemisinin-based combination
therapy, chloroquine and sulfadoxine-pyrimethamine (SP)
had been the first- and second-line treatments, respectively, in
both Swaziland and Mozambique, whereas in South Africa,
sulfadoxine-pyrimethamine had been the first-line treatment.
In KwaZulu-Natal, artemether-lumefantrine was introduced
in February 2001, whereas artesunate plus SP was introduced
as first-line treatment in Mpumalanga Province in January
2003.8 The phased implementation of artesunate plus SP
started in Zone 1 of Maputo Province in 2004, and in the
Boane district (Zone 2A) in January 2005. Extension of this
treatment policy to all zones will be completed during 2006.
Parasite prevalence surveys in Maputo Province, Mozam-
bique. At each of 26 sentinel sites, cross-sectional parasite
surveys were performed on a random sample of 120 individu-
als  2 years of age. Sentinel sites were each divided into
localities from which participants were selected to ensure as
much geographical spread as feasible. Rapid diagnostic tests
that detect histidine-rich protein 2 (HRP-2) antigen (ICT;
Global Diagnostics, Cape Town, South Africa, and Kat
Quick; Kat Medical, Johannesburg, South Africa) were used
to assess prevalence of Plasmodium falciparum infection. In-
dividuals who tested positive were treated, initially with chlo-
roquine, and from 2001 with SP. In each zone, at least one
survey was conducted in June before IRS intervention to pro-
vide estimates of pre-spraying baseline prevalence of P. fal-
ciparum infection. Post-intervention surveys were conducted
in June of each subsequent year. All age categories were
sampled in December 1999, and subsequent surveys were
confined to children 2 to < 15 years of age.
The sentinel site specific sample size was determined to
allow detection of a significant change at the 5% significance
level, assuming a reduction in P. falciparum prevalence of at
least 20% after intervention. Prevalence was calculated an-
nually for each zone, and 95% confidence intervals (CIs)
were calculated using variance estimates that took account of
clustering by sentinel site using the Rao and Scott correction,9
as implemented in the statistical software package STATA.10
Sentinel sites were considered the primary sampling unit. Lo-
gistic regression, allowing for complex survey designs, was
performed to estimate the mean effect on prevalence of in-
fection caused by each spray round, adjusted for differences
in P. falciparum prevalence at baseline. To test for a secular
time trend over the study period, a logistic regression model
was used to compare baseline prevalence of infection in dif-
ferent years. This was possible because of the phased intro-
duction of the intervention, thus providing baseline data over
a range of years.
Malaria case notification data: South Africa and Swaziland.
The number of malaria cases (confirmed microscopically or
by antigen testing) for Swaziland and South Africa were ob-
tained from their national Malaria Information Systems
(MIS), because malaria is a notifiable disease in these coun-
tries. The MIS was designed to document all malaria cases
notified by health facilities, and in the case of South Africa,
includes actively detected cases during studies by field staff of
malaria outbreaks or while conducting random household vis-
its and in follow-up of confirmed cases. Although the South
African MIS collects information on whether a case was “im-
ported” or “local,” this information was not consistently
available for all study years, particularly when the case load
was high. It was therefore decided not to use the data on
imported cases for the purpose of this study.
Mosquito collection in Maputo Province, Mozambique.
Mosquitoes were collected from 138 window traps that were
fitted to selected houses at all sentinel sites. Houses with
window traps were treated in the same way as other houses in
the intervention area. Window traps were emptied daily, and
mosquitoes were preserved in specimen jars that were col-
lected monthly. Anophelines were morphologically classified
and recorded as Anopheles (An). gambiae sensu lato (s.l.) and
An. funestus s.l.,11 initially at the South African Medical Re-
search Council (MRC), and following training, at the LSDI
center in Mozambique. Molecular analysis of specimens was
undertaken at MRC laboratories in Durban. DNA was ex-
tracted from heads and thoraces of mosquitoes,12 and mem-
ber species of the An. gambiae complex and of the An. fu-
nestus group were identified using polymerase chain reaction
(PCR) techniques.13,14 PCR was also used to determine P.
falciparum sporozoite status of all genetically identified An.
gambiae s.l. and An. funestus s.l. mosquitoes.11,15 Numbers of
mosquitoes per trap per night were calculated for each vector
species, both pre- and post-IRS. Using the species-specific
estimated sporozoite prevalence, the number of infective
mosquitoes per trap per night by species was calculated; the
ratio of infective numbers per trap per night post-spraying,
relative to pre-spraying, was defined as the relative transmis-
FIGURE 1. Map of the LSDI malaria control zones and location of
sentinel sites. BWA, Botswana; MOZ, Mozambique; NAM, Namibia;
ZAF, South Africa; SWZ, Swaziland; ZWE, Zimbabwe.
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sion index. The significance test comparing sporozoite preva-
lence in mosquitoes post-spraying with pre-spraying was car-
ried out using generalized estimating equations,16 as imple-
mented in STATA,10 to allow for the correlation structure in
the data.
Ethical considerations. Ethical approval for the study was
obtained from the South African Medical Research Council
and the Ministries of Health in Swaziland and Mozambique.
RESULTS
Plasmodium falciparum prevalence in Maputo Prov-
ince, Mozambique. A total of 15,508 individuals were tested
for parasitemia in the five zones of the Mozambican study
area between December 1999 and June 2005, using rapid di-
agnostic tests (RDTs).
In 1999 in Zone 1, the average infection rate in children
(age, 2–14 years) was 64% compared with 30% in adults (rela-
tive risk [RR], 2.12; 95% CI, 1.87–2.41), with no evidence of
heterogeneity in RRs between sites (P  0.90). Prevalence
surveys in Mozambique were subsequently restricted to chil-
dren between 2 and < 15 years of age.
Plasmodium falciparum prevalence estimated from pre-
spray baseline surveys was > 60% for children 2–14 years in
all zones, regardless of the year during which the baseline
survey was conducted (Table 1). A logistic regression model
of prevalence of infection at baseline (pre-IRS) showed no
significant difference in P. falciparum prevalence (P  0.79)
between baseline surveys undertaken from 1999 to 2003.
There was a decline in P. falciparum prevalence in each
zone in each year after the introduction of IRS, except for in
Zone 2A in 2002 and 2003, when IRS was interrupted (Table
1). The logistic regression model of prevalence of infection
(excluding Zone 2A), with zone and number of years since
baseline as explanatory variables, shows that prevalence at
baseline was significantly higher in Zone 1A compared with
Zone 1 (odds ratio [OR], 2.6; 95% CI, 1.3–5.1). There was no
significant difference in prevalence at baseline between Zone
1 and the remaining zones. There was a significant reduction
in prevalence for each year after intervention across all zones
(OR, 0.48/intervention year; 95% CI, 0.42–0.56; P < 0.001).
There was no significant difference in the annual reduction in
prevalence since baseline between different zones (P  0.74
for test for interaction between the effects of intervention
years and zones).
In Zone 2A, average P. falciparum prevalence declined
from 76% in the pre-spraying surveys of 1999 and 2000 to
33% after the first year of spraying, but rebounded to 59% by
June 2003 after interruption of spraying. After the resump-
tion of IRS, prevalence decreased steadily to 23% by June
2005 (Table 1).
Malaria cases notified in Swaziland and South Africa. The
total number of notified confirmed malaria cases for Swazi-
land and South Africa decreased substantially between 1999/
2000 and 2004/2005 (Table 2). The reductions were particu-
larly large in those districts of KwaZulu-Natal, Swaziland, and
Mpumalanga, which share borders with the intervention area
in Mozambique.
Mosquito vector identification, abundance, and infection
prevalence in Maputo Province, Mozambique. Anopheles
arabiensis, An. merus, and An. quadriannulatus were the
three member species of the An. gambiae complex genetically
identified during the study period (Table 3). An. arabiensis
accounted for 85% of identifications before IRS and 35%
after IRS; An. merus increased to 58% after IRS. Five species
of the An. funestus group were identified, the majority being
An. funestus s.s. The relative numbers of An. gambiae s.l. and
TABLE 1
Prevalence of P. falciparum infection in children 2–14 years by zone and year estimated from prevalence surveys in the intervention area in
Mozambique, with years pre-IRS results shaded (%; sample surveyed [n]; 95% CI)
Year 1999 2000 2001 2002 2003 2004 2005
Zone 1 % (n)
[95% CI]
65% (597)
[45–80%]
60% (918)
[36–81%]
38% (807)
[25–53%]
22% (824)
[11–39%]
8% (792)
[5–13%]
7% (839)
[5–11%]
4% (698)
[3–6%]
Zone 1A % (n)
[95% CI]
88% (397)
[79–93%]
63% (592)
[48–75%]
36% (614)
[24–49%]
17% (714)
[13–21%]
21% (600)
[11–37%]
21% (599)
[8–46%]
Zone 2 % (n)
[95% CI]
69% (955)
[58–79]
34% (992)
[25–45]
30% (954)
[20–42]
20% (935)
[13–30]
Zone 3 % (n)
[95% CI]
70% (617)
[54–81]
58% (579)
[42–73]
33% (570)
[19–50]
Zone 2A* % (n)
[95% CI]
73 (101)
[62–82]
79 (120)
[70–86]
32 (130)
[23–43]
51 (117)
[38–64]
59 (118)
[49–69]
39 (120)
[28–52]
23 (114)
[15–34]
* In zone 2A, the intervention was interrupted from 2002 to 2003.
TABLE 2
Notified confirmed malaria case totals for Swaziland and the two adjacent malaria-endemic provinces in South Africa for the period July 1999
to June 2003 and the percentage change in case numbers per malaria season in comparison with the baseline year of 1999/2000
Malaria season
Swaziland KwaZulu-Natal Mpumalanga
Cases
Percent
change Cases
Percent
change Cases
Percent
change
1999/2000 4,005 41,077 13,856
2000/2001 1,395 −56 16,985 −59 12,799 −8
2001/2002 756 −81 2,818 −93 9,391 −32
2002/2003 343 −91 1,709 −96 4,068 −71
2003/2004 614 −85 4,200 −90 4,738 −66
2004/2005 200 −95 1,778 −96 3,099 −78
A malaria season is the period from 1 July of 1 year to 30 June of the next.
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An. funestus s.l caught exiting window traps were substan-
tially reduced after IRS. Only An. arabiensis, An. merus, and
An. funestus s.s. were found to contain sporozoites; the preva-
lence of sporozoites decreased after spraying in all three spe-
cies. The relative transmission index (the number of infective
mosquitoes per trap per night relative to pre-intervention)
was 0.002 for An. arabiensis, 0.067 for An. merus, and 0.016
for An. funestus s.s.
DISCUSSION
Before initiating vector control activities in Mozambique,
P. falciparum malaria prevalence among children was high in
all zones studied, with average infection by zone ranging from
62% to 86%. These results were similar to prevalence surveys
conducted during the 1937/38 season in 10 areas in Zone 1,
which showed high parasite prevalence with an average of
86% of children 1 to < 15 years of age infected.17 Pre-malaria
control parasite prevalence in KwaZulu-Natal in 1932 was
similar to the baseline data from Mozambique reported in this
study, with 73% infection in children up to 15 years of age and
42% in adults.3 Age-specific P. falciparum infection preva-
lence in Zone 1 was as expected in high-risk malaria areas
without malaria control programs in that infection in the
< 15-year-old categories was approximately double that found
in the older age groups, reflecting partial immunity acquired
with increasing age after repeated malaria infections.18
Indoor residual spraying using carbamate insecticide in
Mozambique was associated with a statistically significant re-
duction in parasite prevalence in all zones with an OR of 0.48
(95% CI, 0.42–0.56) per intervention year. Because these re-
ductions were significant across all zones, and ACTs were
only introduced in two of the five zones in the last year of this
study, the overall reduction in P. falciparum prevalence in
southern Mozambique was largely attributable to IRS. The
implementation of ACTs in South Africa is considered an
important contributor to improved malaria control through
improved cure rates and decreased gametocyte carriage.8
This study has shown the benefits of reducing transmission
intensity by establishing vector control before introducing de-
finitive diagnosis, followed by ACTs as first-line treatment.
Entomologic surveillance showed radical reductions in
numbers of mosquitoes caught in window traps after the in-
troduction of IRS for all three vectors that were implicated in
malaria transmission. In An. arabiensis and An. funestus s.s.,
the decrease in sporozoite prevalence after IRS was statisti-
cally significant. Although the reduction in sporozoite preva-
lence was not statistically significant in An. merus, the major-
ity of post-spraying sporozoite-positive An. merus specimens
were found during the first intervention year. Table 3 shows
that relative abundance of An. merus was low before IRS was
introduced, confirming that it was not a major vector in the
study area. While this species constituted a larger proportion
of all An. gambiae s.l. specimens captured after spraying than
before spraying, this is mainly a reflection of the dispropor-
tionately large decline in An. arabiensis numbers after the
introduction of IRS.
This is the first application using the carbamate insecticide
bendiocarb in a large-scale house spraying program in Africa,
and results are comparable with historical data using other
insecticides. This includes data for the same area of southern
Mozambique over the period 1961–1969 when all houses were
sprayed annually with DDT and parasite prevalence rates
were reduced to < 5% in all areas, an effect that was sustained
for the duration of the campaign.19 Similar parasite preva-
lence reductions were obtained in the Pare–Tavete area of
Tanzania after house spraying with dieldrin,20 in the Kisumu
area of Kenya after application of fenitrothion,21 and in Zan-
zibar and Pemba in Tanzania after DDT house spraying.22 A
more recent example is that of Bioko, Equatorial Guinea,
where prevalence of infection was reduced from 46% to 32%
after the first round of spraying.23 All of these interventions
recorded significant reductions in parasite prevalence after
TABLE 3
Identification of member species, abundance, and transmission rates of malaria-transmitting mosquitoes caught in window traps in intervention
areas of Mozambique,§ 1999–2005
An. gambiae s.l. An. funestus s.l.
Pre-IRS Post-IRS Pre-IRS Post-IRS
Total number of mosquitoes collected 5,577 969 8,830 2,107
Number tested by PCR 903 721 818 575
Percent An. arabiensis 85 35 Percent An. funestus s.s. 95 65
Percent An. merus 11 58 Percent An. rivulorum 1 24
Percent An. quadriannulatus 4 7 Percent An. vaneedeni 0 3
Percent An. parensis 1 2
Percent An. leesoni 3 6
An. gambiae s.l.
An. funestus s.s.Pre-IRS Post-IRS Pre-IRS Post-IRS
An. arabiensis An. merus Pre-IRS Post-IRS
Total estimated 4,740 339 613 562 8,389 1,370
Mean/trap/100 nights (density) 14.9 0.2 1.9 0.4 26.3 0.9
Sporozoite prevalence, %(n), p 7.1 (758) 0.8 (239),
p 0.002
2.2 (91) 0.7 (413),
p 0.25
4.7 (773) 2.2 (367),
p 0.04
Transmission index* 1.058 0.002 0.04 0.003 1.236 0.020
Transmission index relative to baseline 1.00 0.002 1 0.067 1.0 0.016
§ Excluding zone 2A, where the intervention was interrupted.
* The estimated number of infective mosquitoes exiting window traps.
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the initial spraying round, with the mosquito vector An. fu-
nestus s.l. reduced to negligible levels or eliminated and An.
gambiae s.l. populations reduced to very low numbers. In our
study, the substantial reductions in An. funestus s.l. and An.
gambiae s.l. populations after IRS confirm the effectiveness of
large-scale vector control by sustained indoor residual spray-
ing in Africa.
Conteh and others24 compared the cost and cost effective-
ness of using carbamates for vector control in Mozambique
with the findings of costing studies of other IRS programs and
concluded that the cost per person covered per year in the
LSDI was mid-to-high in the ranking of theses studies, but
showed how overall cost would decrease if cheaper insecti-
cides such as DDT were substituted. Both IRS and insecticide
treated nets (ITNs) have been shown to be attractive malaria
interventions in low- and middle-income countries.24,25
A substantial proportion of malaria cases in Swaziland and
South Africa are annually classified as imported, the majority
originating in Mozambique.26 Ngxongo27 found that 69% of
the KwaZulu Natal malaria cases were detected in the district
bordering Mozambique. Thus, it is not surprising that the
reduction in prevalence of the previously uncontrolled reser-
voir of infection in southern Mozambique would impact on
transmission in the adjoining areas, particularly KwaZulu-
Natal and Swaziland. This is particularly supported by the
95% reduction in malaria cases recorded in Swaziland, where
no major changes in malaria control occurred during the
study period (Table 2). In Mpumalanga Province in South
Africa, which only partially borders Zone 1, malaria case no-
tifications decreased by 78%.
The LSDI regional malaria control initiative has markedly
reduced P. falciparum malaria prevalence among children in
southern Mozambique and reduced malaria transmission in
neighboring areas with established malaria control. This study
shows how a regional approach to communicable disease con-
trol can have significant public health benefits in terms of
decreased human morbidity and averted treatment costs. It
also confirms the effectiveness of large-scale vector control in
endemic malaria areas. Based on these results, additional
funding has been secured to extend malaria vector control in
Mozambique to a further area of 75,000 km2, which will result
in a contiguous area of > 195,000 km2 inhabited by > 6 million
people in the three countries being protected. There is little
doubt that this regional approach will contribute to “Rolling
Back Malaria” and reduce the economic burden of malaria
across all three countries, providing a strong argument for
ongoing investment by these neighboring countries in re-
gional malaria control.
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